SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
Figure 6.Correlation analysis of SAAL1 expression with tumor-infiltrating immune cells and TME-relevant signatures in various cancer types. (A) Tumor-infiltrating immune cells. (B) TME-relevant signatures. *P<0.05; **P<0.01; ***P<0.001.